Rare Disease Moonshot - Morris & Chapman
25503
portfolio_page-template-default,single,single-portfolio_page,postid-25503,ajax_updown_fade,page_not_loaded,boxed,select-child-theme-ver-1.0.0,select-theme-ver-1.7,

Rare Disease Moonshot

EFPIA

95% of the 6,000-7,000 identified rare diseases don’t have an approved therapy. For most of these diseases, research is effectively non-existent. The search for new treatments is thwarted by enormous scientific challenges. At the current pace, it would take over 100 years to develop treatments for all rare conditions.

Public-private partnerships could help pool resources to solve problems more quickly, reduce fragmentation and scale up existing initiatives to make a real difference for patients. That’s why a coalition of partners is joining forces to accelerate research in rare and paediatric diseases and bring new therapies to patients.

We designed and developed the Rare Disease Moonshot website.

2022

| Web